Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margherita Nannini

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 3, 2016
Long-term outcome of molecular subgroups of gastrointestinal stromal tumour patients treated with standard-dose imatinib in the BFR14 trial: The wild-type gastrointestinal stromal tumours are not a single group yetMaria A Pantaleo, Margherita Nannini
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 29, 2020
Letter to the editor concerning "Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: Report of a first case"Margherita Nannini, Maria Abbondanza Pantaleo
Histopathology|March 11, 2015
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumoursMargherita Nannini, Guido Biasco, Maria A Pantaleo
World Journal of Gastroenterology|May 16, 2013
Role of molecular analysis in the adjuvant treatment of gastrointestinal stromal tumours: it is time to define itMargherita Nannini, Maria A Pantaleo, Guido Biasco
Clinical Colorectal Cancer|August 24, 2011
The follow-up after radical surgery of colorectal cancer: is it time for a "tailored" strategy?Margherita Nannini, Maria Abbondanza Pantaleo, Guido Biasco
Expert Opinion on Therapeutic Targets|March 10, 2011
New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and futureMargherita Nannini, Guido Biasco, Alessandra Maleddu, et al.
The American Journal of Surgical Pathology|October 15, 2011
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutationsMaria A Pantaleo, Margherita Nannini, Annalisa Astolfi, et al.
Future Oncology (London, England)|November 15, 2014
Treatments for gastrointestinal stromal tumors that are resistant to standard therapiesMaristella Saponara, Maria Abbondanza Pantaleo, Margherita Nannini, et al.
Genes|March 29, 2023
<i>SDHA</i> Germline Mutations in SDH-Deficient GISTs: A Current UpdateAngela Schipani, Margherita Nannini, Annalisa Astolfi, et al.
Journal of Translational Medicine|November 17, 2010
The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs)Maria A Pantaleo, Annalisa Astolfi, Margherita Nannini, et al.
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|March 3, 2016
Long-term outcome of molecular subgroups of gastrointestinal stromal tumour patients treated with standard-dose imatinib in the BFR14 trial: The wild-type gastrointestinal stromal tumours are not a single group yetMaria A Pantaleo, Margherita Nannini
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 29, 2020
Letter to the editor concerning "Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: Report of a first case"Margherita Nannini, Maria Abbondanza Pantaleo
Histopathology|March 11, 2015
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumoursMargherita Nannini, Guido Biasco, Maria A Pantaleo
World Journal of Gastroenterology|May 16, 2013
Role of molecular analysis in the adjuvant treatment of gastrointestinal stromal tumours: it is time to define itMargherita Nannini, Maria A Pantaleo, Guido Biasco
Clinical Colorectal Cancer|August 24, 2011
The follow-up after radical surgery of colorectal cancer: is it time for a "tailored" strategy?Margherita Nannini, Maria Abbondanza Pantaleo, Guido Biasco
Expert Opinion on Therapeutic Targets|March 10, 2011
New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and futureMargherita Nannini, Guido Biasco, Alessandra Maleddu, et al.
The American Journal of Surgical Pathology|October 15, 2011
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutationsMaria A Pantaleo, Margherita Nannini, Annalisa Astolfi, et al.
Future Oncology (London, England)|November 15, 2014
Treatments for gastrointestinal stromal tumors that are resistant to standard therapiesMaristella Saponara, Maria Abbondanza Pantaleo, Margherita Nannini, et al.
Genes|March 29, 2023
<i>SDHA</i> Germline Mutations in SDH-Deficient GISTs: A Current UpdateAngela Schipani, Margherita Nannini, Annalisa Astolfi, et al.
Journal of Translational Medicine|November 17, 2010
The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs)Maria A Pantaleo, Annalisa Astolfi, Margherita Nannini, et al.
Pageof 14